[Effect of induction chemotherapy followed by surgery for bulky N2, T4 non-small cell lung cancer].
It is controversial that the effect of induction chemotherapy for bulky N2, T4 non-small cell lung cancer. We examined a retrospective study to assess this issue. Ten patients with bulky N2, T4 disease were given bronchial arterial infusion consisting of cisplatin (60 mg/m2) and docetaxel hydrate (60 mg/m2) intravenously, followed by standardized surgical resection (group A). Thirty patients had pathological N2, T4 disease after surgery (group B). Pathologically downstaging was seen in 6 patients in group A. The overall long-term survival at 1-, 2-year were 87.5, 87.5% in group A. The long-term survival at 1-, 2-, and 5-year were 78.9, 49.8, 43.6% in group B. There was no statistically significant difference in survival between both groups (p = 0.3015). The effect of induction chemotherapy for bulky N2, T4 non-small cell lung cancer was not demonstrated in our data. We suggest that our induction chemotherapy in group A was effective on T4 disease. A prospective study is needed to investigate our regimen.